Displaying 649 - 660 items out of 696 results
Podcast
… Cancer in Barcelona, Spain discuss highlights and new research from the conference. Dr. Mok is a past president of …
ILCN article
Closing Keynote Highlights Progress, Challenges in Management of SCLC
… Dr. Charles M. Rudin looked back on how small cell research has evolved and what needs remain. … Closing Keynote …
Podcast
… findings presented at the American Association for Cancer Research (AACR) 2025 Annual Meeting. They discuss the results …
ILCN article
In Brief for July 26, 2023
… to immunotherapy by Dr. Drew Pardoll. Lung Cancer Research Foundation announces appointment of new executive …
Committee
… who are pathologists or who specialize in pathology research. The Committee is funded by the IASLC for meetings …
ILCN article
Patient Perspective: Exercise Prescriptions Needed for Lung Cancer Patients
… of a postdiagnosis exercise analysis support this. Researchers found the median overall survival difference was …
ILCN article
TIL Therapy Endures for Carefully Selected Patients: A Q&A with Dr. Benjamin C. Creelan
… Benjamin C. Creelan shares his passion for cell therapy research and insights into current data. … TIL Therapy Endures …
ILCN article
Get Moving and Win During the 2024 Wellness Challenge
… taking part in IASLC’S Wellness Challenge, Step It Up for Research. … Get Moving and Win During the 2024 Wellness …
ILCN article
US FDA’s Review of Single-Country ‘Me Too’ Drugs: A Clinical Trialist Perspective
… of care and limited resources to review applications, researchers say they support the agency’s decision not to …
Resource
… your copy of Advances in Thoracic Oncology Treatment & Research: Legacy of Impact, Future of Promise. IASLC’s 50th …
Podcast
… on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research and celebrate IASLC’s 50th anniversary. To reach a …
Resource
… information about authors' conflicts of interest, the search and selection criteria for source material, and more …